ישראל -
עברית -
Ministry of Health
מודאל קפסולות
rafa laboratories ltd - sulpiride - קפסולות - sulpiride 50 mg - sulpiride - sulpiride - anti - dopaminergic agent for use in peptic ulcer and vomiting vertigo prepsychotic states.
ישראל -
עברית -
Ministry of Health
מודאל פורטה טבליות
rafa laboratories ltd - sulpiride - טבליה - sulpiride 200 mg - sulpiride - sulpiride - anti - dopaminergic agent. 1) for use in peptic ulcer and vomiting vertigo prepsychotic states. 2) at high doses - in psychiatric patients for treatment of depression and apathy.
ישראל -
עברית -
Ministry of Health
סוליאן 400 מג
sanofi israel ltd - amisulpride - טבליות מצופות פילם - amisulpride 400 mg - amisulpride - amisulpride - treatment of schizophrenia.
ישראל -
עברית -
Ministry of Health
סוליאן 100 מג
sanofi israel ltd - amisulpride - טבליה - amisulpride 100 mg - amisulpride - amisulpride - treatment of schizophrenia .
ישראל -
עברית -
Ministry of Health
פרייד 100
unipharm ltd, israel - amisulpride - טבליות מצופות פילם - amisulpride 100 mg - amisulpride
ישראל -
עברית -
Ministry of Health
פרייד 100
unipharm ltd, israel - amisulpride - טבליות מצופות פילם - amisulpride 100 mg - amisulpride
ישראל -
עברית -
Ministry of Health
פרייד 400
unipharm ltd, israel - amisulpride - טבליות מצופות פילם - amisulpride 400 mg - amisulpride
ישראל -
עברית -
Ministry of Health
פרייד 400
unipharm ltd, israel - amisulpride - טבליות מצופות פילם - amisulpride 400 mg - amisulpride
ישראל -
עברית -
Ministry of Health
טייסברי
medison pharma ltd - natalizumab - תרכיז להכנת תמיסה לאינפוזיה - natalizumab 300 mg / 15 ml - natalizumab - natalizumab - tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis . to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. the safety and efficacy of tysabri beyond two years are unknown. because tysabri increases the risk of progressive multifocal leukoencephalopathy (pml), an opportunistic viral infection of the brain that usually leads to death or severe disability. tysabri is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, alternate multiple sclerosis therapies. safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.
ישראל -
עברית -
Ministry of Health
dianatal
גלקסוסמיתקליין -ישראל בע"מ - אחות - vaginal birth facilitation gel in order to ease the birth for mother and child and to reduce perineal trauma by introducing a bioadhesive film onto the birth canal